Immuron (IMRN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited has announced a significant surge in global sales of its Travelan® product, with a record increase of 174% year-over-year, reaching AUD$4.9 million. The impressive sales performance is highlighted by a 223% rise in the Australian market and a noteworthy 74% growth in the U.S. for the financial year of 2024. Buoyed by these results, Immuron anticipates further growth through increased brand investment and distribution, especially in North America.
For further insights into IMRN stock, check out TipRanks’ Stock Analysis page.